Stock BIOPHARMX CORP
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News BioPharmX Corp OTC Bulletin Board

Equities

US09072X1019

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for BioPharmX Corp
Apr. 04 First Motion for Exclusivity Period Extension Approved For Timber Pharmaceuticals, Inc. CI
Mar. 20 Second Revised Disclosure Statement and Plan Approved on Interim Basis for Timber Pharmaceuticals, Inc. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
First Motion for Exclusivity Period Extension Approved For Timber Pharmaceuticals, Inc.
CI
Second Revised Disclosure Statement and Plan Approved on Interim Basis for Timber Pharmaceuticals, Inc.
CI
First Motion for Exclusivity Period Extension Filed by Timber Pharmaceuticals, Inc.
CI
Timber Pharmaceuticals, Inc. Presents Preliminary Results from the ASCEND Trial in A Late-Breaking Session At the 2024 American Academy of Dermatology Annual Meeting
CI
Combined Joint Liquidation Plan & Disclosure Statement Filed by Timber Pharmaceuticals, Inc.
CI
LEO Pharma finalizes acquisition of key assets from Timber Pharmaceuticals
AQ
Motion for Asset Sale Approved for Timber Pharmaceuticals, Inc.
CI
LEO Pharma A/S completed the acquisition of Substantially All the assets from Timber Pharmaceuticals, Inc. (OTCPK:TMBR.Q).
CI
Notice of Selection of Winning Bidder & Asset Purchase Agreement Filed for Timber Pharmaceuticals, Inc.
CI
Notice for Auction Cancellation Filed by Timber Pharmaceuticals, Inc.
CI
Bidding Procedure Approved for Timber Pharmaceuticals, Inc.
CI
Final DIP Financing Approved for Timber Pharmaceuticals, Inc.
CI
Timber Pharmaceuticals to Be Delisted From NYSE American
MT
Timber Pharmaceuticals Announces Commencement of NYSE American Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Market
AQ
Timber Pharmaceuticals Receives Court Approval of Motions to Support Business Operations
MT
Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE American
AQ
Timber Pharmaceuticals, Inc.(NYSEAM:TMBR) dropped from S&P TMI Index
CI
Interim DIP Financing Approved for Timber Pharmaceuticals, Inc.
CI
Motion for Joint Administration Approved for Timber Pharmaceuticals, Inc.
CI
Motion for Joint Administration Filed by Timber Pharmaceuticals, Inc.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TMBR.Q Stock
  4. Stock
  5. News BioPharmX Corp